Cintia Elisabeth Gomez Limia

This researcher works on generating and characterizing induced pluripotent stem cells (iPS cells, which are adult cells reprogrammed to an embryonic-like state) derived from patients with blood cancers and other genetic conditions, such as myelofibrosis, leukemia, and congenital urological disorders. Their work also touches on how specific gene mutations (like TET2 and CALR) affect the reprogramming process and blood cell development. This research helps create patient-specific cell models useful for studying disease mechanisms and testing treatments.

Publication output has been low and irregular over the past decade, with occasional gaps and no more than two papers in any given year.

Generated by claude-sonnet-5 from public bibliographic data · Jul 20, 2026